Skip to main content
Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
17.35
+0.04 (0.23%)
At close: Mar 9, 2026, 4:00 PM EDT
17.31
-0.04 (-0.23%)
After-hours: Mar 9, 2026, 4:00 PM EDT

Avalo Therapeutics Employees

Avalo Therapeutics had 23 employees as of December 31, 2024. The number of employees increased by 4 or 21.05% compared to the previous year.

Employees
23
Change (1Y)
4
Growth (1Y)
21.05%
Revenue / Employee
$8,348
Profits / Employee
-$4,334,826
Market Cap
321.20M

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 202423421.05%
Dec 31, 202319-1-5.00%
Dec 31, 202220-24-54.55%
Dec 31, 2021441341.94%
Dec 31, 2020311372.22%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Related Stocks

Company Name Employees
Puma Biotechnology 172
Cabaletta Bio 151
X4 Pharmaceuticals 143
Nautilus Biotechnology 124
Adlai Nortye 123
Rezolute 75
Protara Therapeutics 33
Opus Genetics 18
Employee Rankings

AVTX News

More News